Two of China's biggest pharmaceutical companies, Shanghai Fosun Pharmaceutical (Group) Co. Ltd. and Shanghai Pharmaceuticals Holding Co. Ltd., have confirmed bids for a stake in Atlanta-based Arbor Pharmaceuticals LLC in a deal that could be worth upward of $2 billion, depending on the valuation.